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Replacement of the C-2 ester group in phosphatidylcholine by the carbamyloxy function rendered its 
liposomes completely stable and longer living in the circulation of rats. 
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1. INTRODUCTION 
The successful application of liposomes as drug 
carriers in therapy [1,2] is largely restricted by their 
major uptake in liver and spleen, and also their 
structural disintegration in blood f3]. Disruption 
of liposomes in the circulation is mainly caused by 
the transfer of their lipid constituents to the high 
density fraction of plasma lipoproteins [4,5]. This 
effect of the lipoprotein is reduced by increasing 
the CH content of the liposomes [6,7] or by an ap- 
propriate choice of the phospholipid component 
[g,lll. 
in an attempt o design liposomes that would be 
stable in blood, we have recently modified phos- 
phatidylcholines by introducing one NH residue 
adjacent to the carbon atom of their C-2 ester 
group [ 121. This change rendered the resulting 
phospho~ipids electively resistant to phospho- 
lipase A2 [12], without adversely affecting the 
physico-chemical properties of the liposomes 
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[12,13]. Further studies with these lipids have 
revealed that complete replacement of egg PC in 
liposomes by MPC prevents serum-induced 
leakage of the entrapped solutes and also inhibits 
the Iipid transfer from liposomes to serum proteins 
[14]. We now report the results of our studies on 
the in vivo stability of the iiposomes consisting of 
MPC and CH. Our data show that these liposomes 
are completely stable and longer living in the cir- 
culation of the injected animals. 
2. MATERIALS AND METHODS 
Egg PC, MPC, egg [methyf-‘4C]PC (35 &i/ 
pmol) and [methyl-‘4C]MPC (15 ,&i/~mol) were 
prepared as in [12]. Al1 these phospholipids ex- 
hibited single spots on siIica gel G-60 thin-layer 
chromatography (TLC) plates. The assay of 
radioactive isotopes was carried out as in [14]. The 
amounts of 6-CF were measured in the absence 
and in the presence of Triton X-100 (1% final con- 
centration, pH 7.4) on an Aminco SPF-500 
fluorimeter using excitation and emission wave- 
Ienghts of 490 and 520 nm, respectively. 
2.1. Liposomes 
Small unilamellar liposomes were prepared from 
40 /cm01 of phospholipid, traces of the correspond- 
ing 14C-IabeIed phospho~ipid (14C, - 100 &i), 
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2Ofimoi of CH and 6-CF (0.2 M) in 2.0 ml Tris- 
buffered saline (10 mM in 0.9% NaCl, pH 7.4) by 
probe so~ica~~on flZ& and fractionated by cen- 
trifu~atio~ at 105 @@Q x g (H-SO fixed angle mtor) 
for 30 ntia at 10°C. Only the Iiposomes found in 
the top two-thirds of the supernatant were used. 
Free and hposomal 6-CF were separated by gel 
filtration of the fractionated liposomes on a 
Sephadex G-50 column (1.5 x 20 cm), The column 
was eluted with the Tris buffer, The liposome-rich 
fractions were pooled together and used in further 
experiments within 1 h after the gel filtration. 
Homogeneity of the liposome preparations was 
routinely analysed by column chromatography on 
Bio-Gel A-%&n. Both egg PCKH and MPCEH 
liposomes invariably eluted with the included 
volume of the Bio-Gel column, and had similar 
size distributions. The outer diameter of liposomes 
was about 30-60 nm, as determined by negative 
staining electron microscopy. 
2.2. Clearance of liposomes from the circulation 
Liposomal preparations (P, 5-7 amol; 14C, 
-10 ,KZi) in buffered saline (l .O ml) were injected 
into tail vein of male rats (albino; average weight 
200 g). Blood was drawn by retro orbital puncture 
into ~~pari~~~~ m ro~ent~fuge tubes at specified 
time intervals, A measured diquot (&2 mi) of 
blood was suspended in the Tris buffer (1.0 ml) 
and centrifuged at 3000 rev./mm (4’C). Measured 
volumes af the diluted plasma were assayed for 
radioactivity and also for free and total (free + li- 
posomal) dye. The amounts of radioactivity and 
the Xiposomal dye remaining in the circulation at 
specified time periods were calculated by assuming 
2 min values as 100%. The amounts of 6-CF that 
remained entrapped at 2 min were 9~9~~~ of the 
trapped amounts prior to the injection. 
Blood (-10~1) from rats was drawn info 
heparinized capillary pipettes immediately (2 min) 
after injecting liposomes in them, and transferred 
to preweighed scintillation vials. It was weighed 
and. treated with 0.1 M NaOH (0,l ml) followed 
by l&Q2 (3O”Io, w/v; 0.1 ml). The sample was kept 
at room temperature for 30-40 min. It was dissolv- 
ed irr the scintillin and anafysed far radioactivity. 
The animals were killed 24 h after the injection 
and their livers and spleens were taken out, These 
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were washed with the Tris buffer, blotted and 
weighed. The tissues were minced and hcmogenis- 
ed in the buffered Mine fBY%, WA). A measured 
portion of each homogenate was assayed for radio- 
activity. ‘33~ amounts of rad~oa~tivity present in 
liver and spleen were calculated as percentages of 
the total injected radioactivity. The total radio- 
activity was calculated from 2 min blood sample 
by assuming the total blood volume as @lb of the 
body weight. Just before sacrificing the animals, 
the radioactivity and 6-CF levels in tatal plasma 
were -3Oolo for MPCKH liposomes. In case of 
egg PCKH lipasomes, c 7% radioactivity and no 
6CF were detected in the plasma samples. 
Small u~il~m~llar liposomes were prepared from 
phospholipids and 50 mol % CH by sonic&ion, 
and fractionated by centrifugation. These 
liposomes were labeled with i4C by including trace 
amounts of the corresponding “‘C-labeled 
phospholipid in the lipid mixture. 6-CF (a,2 M) 
was entrapped in liposomes as the model solute, 
This dye remains completely latent when entrap- 
ped at a high concentration (W_%KE M), and 
fluoresces only upon its leakage and subsequent 
dilution in the surrounding rned~~m flj& 
Measurements of the amounts of the latent dye in 
plasma should, therefore, aIlow accurate rnonitor- 
ing of the liposomal 6-CF in the circuiation of the 
injected animals. 
Time-dependent disappearances of free 6-CF 
from blood was determined by injecting its dilute 
solutions CO.02 M) in rats. More than 95910 of the 
total injected dye was cleared in 60 min, The 
clearance time of 6--CF markedly increased when 
administered after encapsulating it in MPC/CH 
liposomes (fig. lA, solid circles), which was quite 
unhke that observed in egg PCKZH hposomes (fig, 
1A, sotid triangles). The faster clearance of 6-CF 
from the egg PC/CH iiposomes may result from 
the plasma-induced leakage of the entrapped dye 
[7]. This is evident from the differences between 
the rates of clearance of the liposomal iJC and the 
latent 6CF (fig. 1A,B solid triangles). 
The plasma-induced leakage of the entrapped 
6-CF from the liposomes was ascertained by com- 
paring the ratios of liposomal j4C to latent 6-CF at 
a given period of time and 2 min after the injee- 
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Fig. 1. Clearance of liposomal S-CF (A) and 
radioactivity (B) from the circulation of rats after 
injecting hposomes. Each point is the mean of 4-6 
animals. Bars, SD: solid triangles, egg PC/CH 
Iiposomes; solid circles, MPCKH liposomes. 
tion. Fig. 2 shows that this ratio for MPCYCH 
liposomes remains unaltered at least up to 6 h in 
the circulation, suggesting that the blood com- 
ponents do not induce any change in the 
permeability behavior of these liposomes, This is 
quite in accordance with our earlier observation 
that the incubation of MPCKH liposomes with 
serum fairs to acceierate the &ease of the entrap- 
ped solutes [14]_ As observed with serum [14], the 
6-CF efflux from egg PUCH liposomes was 
markedly enhanced in blood (fig. 2). To confirm 
that this enhanced leakage from egg PCKH 
liposomes is due to the lipid transfer to plasma 
proteins [4,5], we have measured the phospholipid 
transfer from liposomes to these proteins (fig. 3). 
The results given in tabIe 1 indicate that from egg 
PCKW liposomes considerably Iarger amounts 
(18-21 %I, 60 min) of the phospho~pid were trans- 
1 f f 
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Fig, 2. The plasma-induced leakage of 6-CF was 
calculated from the ratios of the liposomal 14C to latent 
6-F at a given time period (Ix) and 2 min (t,) after 
injecting Iiposomes in rats. Q is a quotient of 
f’%X5-CF],, and [‘%X-CF‘&,. When Q-values were 
close to one, the liposomes were regarded as stable in the 
circulation, The values greater than one reflected 
plasma-induced leakage of hposomal 6-CF. The 
maximum Q-value obtained for MPCXH liposomes up 
to 6 h in the circulation was 1.12 whereas t.his value for 
egg PCYCH liposomes was 4. Leakage rates of 6-CF 
from MPC/GH liposomes in buffer (pH 7.4) at 37°C 
were almost identical to those from egg PC/CL-L 
liposomes (5-8%, 6 h). Bars represent means of 4-6 
animals f SD. Open bars, egg PC/CH liposomes; solid 
bars, MPUCH liposomes. 
ferred to plasma proteins, as compared to that 
from the MPC/CH liposomes (3-6%, 60 min). 
Also, the major amount of protein-associated 
phospholipid eluted in fractions which match the 
elution profile of HDL (fig. 3). 
These results suggest hat a minor but specific 
structural modification of the phospholipid com- 
ponent can significantly enhance the stability and 
survival times of the liposomes in the circulation. 
The structural change that was introduced in PC 
virtualy had no adverse effect on the physico- 
chemical properties of the fiposomes fI2,13]. In- 
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Fig. 3. Liposomes were injected in rats, and blood 
(-1.0 ml) was drawn into heparinized glass tubes at 
15 min and 60 min after injection. The blood samples 
were centrifuged and a portion of plasma (0.3-0.5 ml) 
was chromatographed over Sepharose 6B column 
(1.4 x 35 cm). Fractions were analysed by measuring 
absorbance at 280 nm on a Spectronic 710 spectrophoto- 
meter and also by scintillation counting of 14C. (A) and 
(B) are elution patterns of plasma samples obtained at 
15 min and 60 min after the injection, respectively. Solid 
line, egg PC/CH liposomes; broken line, MPC/CH 
liposomes. In one experiment, plasma obtained from 
blood of rats that were not injected liposomes was also 
chromatographed as above (C). When liposomes were 
incubated with buffer at 37’C and a portion of this 
mixture was passed through the column, >95% of the 
total radioactivity eluted in fractions 13-17. Pure HDL 
from this column was eluted in fractions 26-32. 
Recoveries of radioactivity and protein from the column 
were at least 90%. The phospholipid transfer from 
liposomes to plasma proteins was calculated from areas 
under the respective peaks. The areas under the peaks 
were expressed as percentages of the total eluted 14C (or 
protein). A summary of data for phospholipid transfer 
is given in table 1. 
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Table 1 
Transfer of phospholipids from liposomes to plasma 
proteins 
Liposomes Phospholipid transfer @o) 
15 min 60 min 
Egg PC, CH 14.61 f 0.29 19.51 * 1.90 
MPC, CH 3.21 + 0.89 4.30 +I 1.52 
Values are the means of 4-6 animals + SD 
Table 2 
Uptake of liposomes in livers and spleens of rats 24 h 
after injection 
Liposomes % of initial (2 min) amount of 
radioactivity in blood 
Liver Spleen 
Egg PC, CH 10.88 + 2.22 0.40~0.11 
MPC, CH 16.45 * 0.80 0.68 * 0.20 
Values are the means of 3-5 animals -t SD 
stead, this change seems to offer the following 
advantages: 
(i) The phospholipase AZ-resisting property of 
MPC could have reduced the capture and lysis 
of the liposomes in liver [ 161: 
(ii) Introduction of the NH residue adjacent to the 
carbon atom of the C-2 ester group leads to a 
more ordered phospholipid packing in PC 
bilayers [13] either due to the interlipid H- 
bonding [13] or because of the stabilization of 
the phospholipid conformation [17-191, which 
in turn might have reduced the lipid transfer to 
HDL [6,11]. 
To examine the validity of these suggestions, we 
have determined the amounts of uptake of 
liposomes in liver and spleen, and also the 
phospholipid transfer to HDL. The data shown in 
table 2 indicate that in case of MPC/CH lipo- 
somes, relatively higher amounts of radioactivity 
were present in liver and spleen. However, these 
amounts should not reflect the higher uptake but 
could arise from the reduced rates of lysis of the 
Iiposomes in these organs [ 161. Furthermore, when 
both MPC/CH and egg PC/CH liposomes were 
separately incubated with HDL (3 h, 37”C), no 
transfer of MPC to the protein was observed. On 
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the contrary, -50% egg PC was transferred under 
identical conditions (A. Bali, S. Dhawan, and 
CM. Gupta, unpublished results). 
This study clearly demonstrates that an ap- 
propriate tailoring of the phospholipid component 
can significantly minimize the basic drawbacks 
associated with liposomes as drug carriers. The 
phospholipase AZ-resisting property of MPC will 
not result in its long-term toxicity, because this 
lipid would readily be degraded by other phospho- 
lipases [12]. The MPC/CH liposomes may, there- 
fore, find some useful applications as drug carriers 
in therapy. 
[4] Krupp, L., Chobanian, A.V. and Brecher, PI. 
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